UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 8, 2010
SYMMETRY MEDICAL INC.
(Exact name of Registrant as specified in its charter)
|
Delaware
|
|
001-32374
|
|
35-1996126
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
3724 N State Road 15, Warsaw, Indiana 46582
(Address of Principal executive offices, including Zip Code)
(574) 268-2252
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
The 2010 Annual Meeting of Stockholders of Symmetry Medical Inc. (the “Company”) will be held on April 30, 2010, beginning at 1:30 P.M., at the Lexington Lansing Hotel 925 South Creyts Road Lansing, MI 48917.
A stockholder proposal not included in the proxy statement for the Company’s 2010 Annual Meeting will be ineligible for presentation at the meeting unless the stockholder gives timely notice of the proposal in writing to the Secretary of the Company at the principal executive offices of the Company and otherwise complies with the provisions of the Company’s Bylaws. A copy of the Company’s Bylaws may be obtained free of charge from the Company’s web site, www.symmetrymedical.com under the “Investor Relations” tab or by requesting a copy from the Secretary of the Company via written request delivered to its principal executive offices.
________________
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
Symmetry Medical Inc.
|
| |
|
| |
/s/ Fred L. Hite
|
|
Date: March 8, 2010
|
Name: Fred L. Hite
|
| |
Title: Chief Financial Officer
|